Amyotrophic Lateral Sclerosis Registry in Thailand
A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand
Chulalongkorn University
100 participants
Mar 1, 2025
OBSERVATIONAL
Conditions
Summary
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
Eligibility
Inclusion Criteria3
- Diagnosis of ALS according to El Escorial or Gold Coast criteria
- Age ≥ 18 years
- Ability and willingness to provide informed consent
Exclusion Criteria2
- Patients unwilling to provide informed consent
- Patients with alternative diagnoses mimicking ALS
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07175935